Dr. Charles J. Dow, M.D.
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (1987)
- Years since graduation
- 39
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 1,031
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1987Medical school: Tufts University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
MA license 77999
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Beth Israel Deaconess Medical Center Boston, MA
- Boston Medical Center-Brighton Brighton, MA
- New England Baptist Hospital Boston, MA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,031
- Services billed
- 3,006
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| New patient office or other outpatient visit, 60-74 minutes | 582 | 582 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 568 | 329 |
| Established patient office or other outpatient visit, 40-54 minutes | 558 | 330 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 418 | 283 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 229 | 216 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 188 | 185 |
| Ultrasound of heart blood flow, valves and chambers | 152 | 147 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 152 | 147 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 119 | 114 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 56 | 55 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Roxbury Crossing, MA | 252 |
| Metoprolol Succinate Other prescribers in Roxbury Crossing, MA | 234 |
| Atorvastatin Calcium Other prescribers in Roxbury Crossing, MA | 158 |
| Rosuvastatin Calcium Other prescribers in Roxbury Crossing, MA | 104 |
| Lisinopril Other prescribers in Roxbury Crossing, MA | 79 |
| Clopidogrel (clopidogrel bisulfate) Other prescribers in Roxbury Crossing, MA | 78 |
| Amlodipine Besylate Other prescribers in Roxbury Crossing, MA | 69 |
| Furosemide Other prescribers in Roxbury Crossing, MA | 66 |
| Carvedilol Other prescribers in Roxbury Crossing, MA | 57 |
| Entresto (sacubitril/valsartan) Other prescribers in Roxbury Crossing, MA | 52 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 45 payments worth $36,475 in total to this clinician.
| Novo Nordisk Inc | $35,926 |
|---|---|
| E.r. Squibb & Sons, L.l.c. | $230 |
| Alnylam Pharmaceuticals Inc. | $82.71 |
| Amgen Inc. | $73.41 |
| AstraZeneca Pharmaceuticals LP | $55.28 |
| Bayer HealthCare Pharmaceuticals Inc. | $48.29 |
| Esperion Therapeutics, Inc. | $23.57 |
| Novartis Pharmaceuticals Corporation | $18.62 |
| Compensation for services other than consulting (speaking, faculty) | $33,176 |
|---|---|
| Travel and Lodging | $2,025 |
| Food and Beverage | $1,274 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $9,970 |
| Novo Nordisk Inc Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $8,831 |
| Novo Nordisk Inc Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $8,439 |
| Novo Nordisk Inc Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $5,103 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $834 |
| Novo Nordisk Inc Mar 27, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Raleigh, NC · in-kind | $663 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $445 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $399 |
| Novo Nordisk Inc Mar 27, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Raleigh, NC · in-kind | $203 |
| Novo Nordisk Inc Sep 10, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Buffalo, NY · in-kind | $194 |
All 11 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Novo Nordisk Inc Dec 3, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $5,103 |
| Novo Nordisk Inc Oct 7, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $834 |
| Novo Nordisk Inc Sep 10, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $8,439 |
| Novo Nordisk Inc Sep 10, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Buffalo, NY · in-kind | $194 |
| Novo Nordisk Inc Mar 27, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $8,831 |
| Novo Nordisk Inc Mar 27, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Raleigh, NC · in-kind | $663 |
| Novo Nordisk Inc Mar 27, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Raleigh, NC · in-kind | $203 |
| Novo Nordisk Inc Mar 8, 2025 | Compensation for services other than consulting (speaking, faculty) Ozempic · Diabetes | $9,970 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $445 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $399 |
| Novo Nordisk Inc Mar 8, 2025 | Travel and Lodging Ozempic · Diabetes · travel to Orlando, FL · in-kind | $121 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.